Sofinnova Partners β 2022 Investments
7 investments dated 2022 Β· listed companies and verified rows first Β· show all
Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform.
BiotechHealthtechMedical DevicesNew York, US
Sohail Tavazoie(Co-Founder & Chair of Scientific Advisory Board)Masoud Tavazoie(Co-Founder & Advisor)in
Co-investorsVivo CapitalSands Capital VenturesStart CapitalNovo Holdings
Microphyt develops microalgae-based ingredients and products for nutrition, dietary supplements, and personal care using proprietary bio-reactor technology.
BiotechFoodTechHealthtechNew MaterialsWellness & Fitness
Arnaud Muller-FeugaVincent Usache(Managing Director)in
Co-investorsBpifranceSupernova Invest
Biosyntia is a Copenhagen-based industrial biotech company that uses strain engineering and fermentation to produce sustainable, bio-based active ingredients like vitamin B7, replacing petrochemical-derived alternatives for cosmetics and nutrition markets.
Copenhagen, DK
Co-investorsEuropean Circular Bioeconomy FundNovo Holdings
Elicit Plant develops agricultural solutions that trigger plants' natural defenses to help field crops resist water stress and adapt to climate change.
AgTechBiotechClimate Tech
Olivier Goulay(Founder)in
Co-investorsEuropean Circular Bioeconomy Fund
Nephris is a biotech company developing first-in-class therapies for diabetic chronic kidney disease.
BiotechDigital Health
Prometheus Materials develops low-carbon cement and concrete technology, marketed as ProZERO, using algae-based biotechnology as a replacement for portland cement in ready-mix and construction applications.
CleantechConstruction TechNew MaterialsLongmont, US
Loren Burnett(President, CEO and Co-founder)inSherri Cook(Advisor and Co-founder)inMija Hubler(Engineering Advisor and Co-founder)inWil Srubar III(Technology Advisor and Co-founder)inJaclyn Gruber(Chief Marketing Officer)in
BoardJosko Bobanovic(Director)
Co-investorsAutodesk Foundation
Protera builds functional protein ingredients for the food industry using its madi platform, which combines generative AI and computational biology to design novel proteins produced through precision fermentation.
AI & Machine LearningBiotechFoodTech
Co-investorsSOSV
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.